INTRODUCTION {#sec1-1}
============

Burn injury is a major problem in many parts of the world. It has been estimated that 75% of all deaths following burns are related to infection. Thermal injury destroys the skin barrier that normally prevents invasion by microorganisms. This makes the burn wound the most frequent origin of sepsis in these patients.\[[@CIT1]\]

Initially, the burnt area is considered free of microbial contamination. But gram-positive bacteria in the depth of sweat glands and hair follicles heavily colonize the wounds within 48 h of the injury.\[[@CIT2][@CIT3]\]

Topical antimicrobials decrease microbial overgrowth but seldom prevent further colonization with other potentially invasive bacteria and fungi. These are derived from the patient\'s gastrointestinal and upper respiratory tract and the hospital environment.\[[@CIT4][@CIT5]\]

Following colonization, these organisms start penetrating the viable tissue depending on their invasive capacity, local wound factors and the degree of the patient\'s immunosuppression.\[[@CIT5]\] If sub-eschar tissue is invaded, disseminated infection is likely to occur.\[[@CIT3]\] Great emphasis must therefore be placed on early identification of local signs of invasive burn wound infection.

The causative infective microorganisms in any burn facility change with time.\[[@CIT6][@CIT7]\] Individual organisms are brought into the burns ward on the wounds of new patients. These organisms then persist in the resident flora of the burn treatment facility for a variable period of time, only to be replaced by newly arriving microorganisms. Introduction of new topical agents and systemic antibiotics influence the flora of the wound.\[[@CIT6][@CIT7]\]

Thus, it is just not sufficient to be aware of the microorganisms that pose a problem for burn patients. To have an in-depth knowledge of the organisms that are predominant in that particular treatment facility during the particular period along with their sensitivity pattern is vital as many septic burn patients need to be treated with antibiotics before the results of microbiological cultures are available. This would be crucial to reduce the overall infection-related morbidity and mortality.

In the present study, we determined the nature of microbial wound colonization in 1534 patients. The major objectives were to determine:

Which microorganisms were prevalent in our treatment facility,Their antibiotic sensitivity pattern.

MATERIAL AND METHODS {#sec1-2}
====================

Patients {#sec2-1}
--------

This is a retrospective analysis of the study of isolates from the burns unit of Bai Jerbai Wadia Hospital for children, Mumbai. The hospital caters exclusively to a paediatric population. In our study, the youngest child was a month old and the oldest, 15 years old. Between 1994 and 2006, a total of 9333 samples were processed. The sex distribution of the patients and the aetiology of burns are presented in Tables [1](#T0001){ref-type="table"} and [2](#T0002){ref-type="table"}. It is interesting to note that in our series, male children outnumbered females by 13.2%. Mortality figures are presented in [Table 3](#T0003){ref-type="table"}. This study focuses exclusively on the microbiological profile and no attempt has been made to correlate this with clinical data. We desire to do this as a separate study.

###### 

Age sex distribution age - 1 month - 15 years

  *Year*            *1994*   *1995*   *1996*   *1997*   *1998*   *1999*   *2000*   *2001*   *2002*   *2003*   *2004*   *2005*   *2006*   *Total*                                                                                                      
  ----------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ -------------- ----- ------
  No. of Patients   112      129      153      144      157      132      135      122      92       96       77       73       112      1534                                                                                                         
                                                                                                                                                                                                                                                      
                    No.      \%       No.      \%       No.      \%       No.      \%       No.      \%       No.      \%       No.      \%        No.   \%     No.   \%     No.   \%     No.   \%     No.   \%     No.   \%     \*Tested for   NO.   \%
  Male              58       51.8     75       58.1     84       54.9     70       48.6     92       58.6     80       60.6     81       60.0      72    59.0   56    60.9   58    60.4   44    57.1   42    57.5   50    44.6   1534           868   56.6
  Female            54       48.2     54       41.9     69       45.1     74       51.4     65       41.4     52       39.4     54       40.0      50    41.0   36    39.1   38    39.6   33    42.9   31    42.5   62    53.9   1534           666   43.4

###### 

Aetiology

  *Year*       *1994*   *1995*   *1996*   *1997*   *1998*   *1999*   *2000*   *2001*   *2002*   *2003*   *2004*   *2005*   *2006*   *Total*                                                                                                       
  ------------ -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ -------------- ------ ------
  Total        112      129      153      144      157      132      135      122      92       96       77       73       112      1534                                                                                                          
                                                                                                                                                                                                                                                  
               No.      \%       No.      \%       No.      \%       No.      \%       No.      \%       No.      \%       No.      \%        No.   \%     No.   \%     No.   \%     No.   \%     No.   \%     No.   \%     \*Tested for   NO.    \%
  Scalds       82       73.2     98       76.0     105      68.6     108      75.0     124      79.0     100      75.8     83       61.5      96    78.7   65    70.7   75    78.1   62    80.5   56    76.7   94    83.9   1534           1152   75.1
  Flame        15       13.4     18       13.9     25       16.4     22       15.3     15       9.6      20       15.1     32       23.7      18    14.8   14    15.2   14    14.6   8     10.3   9     12.3   9     8.0    1534           221    14.4
                                                                                                                                                                                                                                                  
  Crackers     3        2.7      3        2.3      16       10.4     4        2.8      5        3.2      4        3.0      7        5.2       0     0.0    2     2.2    3     3.1    0     0.0    1     1.4    4     3.6    1534           52     3.4
                                                                                                                                                                                                                                                  
  Contact      9        8.0      5        3.9      5        3.3      5        3.5      2        1.3      5        3.7      4        3.0       3     2.5    4     4.3    2     2.1    2     2.6    2     2.7    1     0.9    1534           49     3.2
                                                                                                                                                                                                                                                  
  Electrical   1        0.9      4        3.1      2        1.3      3        2.1      5        3.2      1        0.8      6        4.4       2     1.6    4     4.3    2     2.1    4     5.2    3     4.1    3     2.7    1534           40     2.6
                                                                                                                                                                                                                                                  
  Chemical     2        1.8      1        0.8      \-       \-       0        0.0      4        2.5      1        0.8      3        2.2       0     0.0    0     0.0    0     0.0    1     1.3    2     2.7    1     0.9    1534           15     1
                                                                                                                                                                                                                                                  
  Tar          0        0.0      0        0.0      0        0.0      1        0.7      2        1.3      1        0.8      0        0.0       0     0.0    0     0.0    0     0.0    0     0.0    0     0.0    0     0.0    1534           4      0.3
                                                                                                                                                                                                                                                  
  Frostbite    0        0.0      0        0.0      0        0.0      1        0.7      0        0.0      0        0.0      0        0.0       0     0.0    0     0.0    0     0.0    0     0.0    0     0.0    0     0.0    1534           1      0.1

###### 

Mortality statistics

  *Year*                  *1994*   *1995*   *1996*   *1997*   *1998*   *1999*   *2000*   *2001*   *2002*   *2003*   *2004*   *2005*   *2006*   *Total*                                                                                                   
  ----------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ----- ------ ----- ------ ----- ------ ----- ----- ----- ----- ----- ----- -------------- ----- ------
  Total no. of Patients   112      129      153      144      157      132      135      122      92       96       77       73       115      1534                                                                                                      
                                                                                                                                                                                                                                                         
                          No.      \%       No.      \%       No.      \%       No.      \%       No.      \%       No.      \%       No.      \%        No.   \%     No.   \%     No.   \%     No.   \%    No.   \%    No.   \%    \*Tested for   No.   \%
  No. of Deaths           11       9.8      8        6.2      13       804      12       8.3      14       8.9      13       9.8      20       14.8      18    14.8   12    13.0   13    13.5   7     9.1   6     8.2   8     7.0   1534           155   10.1

Wound treatment {#sec2-2}
---------------

Closed dressings using silver sulphadiazine ointment were used in all patients without exception. The burn wounds were washed daily to remove necrotic tissue and the remnants of the previous day\'s ointment.

Procedure for wound sampling {#sec2-3}
----------------------------

Microbial colonization of all wounds was studied from the time of admission to discharge. On admission, the sampling procedure included swabs that were taken from clinically deep areas of the burn wound prior to any cleansing. Swabs were taken twice weekly. The bandages were removed, the remnants of the previous day\'s ointment were washed away and the wounds were swabbed and cultured as follows: A sterile cotton swab is moistened with sterile normal saline. This swab is rubbed onto the burn wound surface. Swabs are taken from areas which appear deep, areas with discharge, thick eschar, etc. The soabs are then sent for culture.

Microbiology {#sec2-4}
------------

The swabs are transported to the laboratory for processing immediately. They are streaked onto a differential medium (e.g.; Mac Conkey agar\] and an enriched medium (e.g.; blood agar). Isolation is carried out by the conventional T-method using sterile nichrome loop. These plates are incubated at 37 °C for 16-18 h. The basic aim was to isolate the organisms predominant on the burn wound and determine their sensitivity to various antibiotics for clinical purposes.

Antibiotic sensitivity of isolates obtained from the burn wound was carried out by filter paper disc diffusion method (Kirby Bauer method). Sterile commercially available filter paper discs, onto which a definite amount of antibiotic has been absorbed, are used. Since the antibiotic in the disc tends to diffuse more onto the surface of the agar than into the deeper layers, the plate is surface spread with the organisms. A broth culture of the isolate is prepared using sterile peptone water comparable to 0.5 Macfarlands turbidity standard (i.e.1×10^7^ to 1×10^8^ organisms/ml). Approximately 0.2 ml of this broth culture is surface spread onto sterile Mac Conkey agar plate (for gram-negative organisms)/sterile blood agar plate (for gram-positive organisms), so as to get a matt growth.

Sterile antibiotic discs are equidistantly placed on these plates and gently pressed onto the medium with the help of sterile forceps to ensure complete contact with the agar surface. The plates are incubated at 37° C for 16 to 18 h. Zones of inhibition are measured in millimetres and the organisms classified as sensitive or resistant according to the zone size interpretation chart. It must be noted that our antibiotic sensitivities were not carried out on Mueller Hinton agar as advocated by some authors\[[@CIT20][@CIT21]\]. Subsequently, we have carried out a comparative study and tested antibiotic sensitivities for 10 different burn wound isolates on Mueller Hinton and Blood agar/ Mac Conkey agar and found no significant difference in the \[Figure [1](#F0001){ref-type="fig"} & [2](#F0002){ref-type="fig"}\] results.

![Comparitive study with mueller hinton agar and blood agar](IJPS-42-213-g001){#F0001}

![Comparitive study with mueller hinton and mac conkey agar](IJPS-42-213-g002){#F0002}

RESULTS {#sec1-3}
=======

In the present study, a total of 9333 samples were processed from patients admitted to the burns unit; 1281 samples (13.72%) showed absence of bacterial pathogens \[[Table 4](#T0004){ref-type="table"}\].

###### 

Bacteriological studies

  *Year*     *1994*   *1995*   *1996*   *1997*   *1998*   *1999*   *2000*   *2001*   *2002*   *2003*   *2004*   *2005*   *2006*   *Total*                                                                                                        
  ---------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ------ ------ ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ -------------- ------ ------
  Patients   112      129      153      144      157      132      135      122      92       96       77       73       112      1534                                                                                                           
                                                                                                                                                                                                                                                 
             No.      \%       No.      \%       No.      \%       No.      \%       No.      \%       No.      \%       No.      \%        No.    \%     No.   \%     No.   \%     No.   \%     No.   \%     No.   \%     \*Tested for   No.    \%
  Total      336               524               782               1184              1244              1080              949                879           472          519          422          383          559          1534           9333   
  No         58       17.3     74       14.1     175      22.4     202      17.1     205      16.5     107      9.9      125      13.2      105    11.9   60    12.7   31    6.0    29    6.9    47    12.3   63    11.3   1534           1281   13.7
  Growth                                                                                                                                                                                                                                         
  Growth     278      82.7     450      85.9     607      77.6     982      82.9     1039     83.5     973      90.1     824      86.8      774    88.1   412   87.3   488   94.0   393   93.1   336   87.7   496   88.7   1534           8052   86.3
  Isolates   379               696               1016              1931              2059              1557              1530               1362          689          972          805          509          634          1534                  

The most common isolate was *Klebsiella* (33.91%) followed by *Pseudomonas aeruginosa* (31.84%). A detailed break-up is given in [Table 5](#T0005){ref-type="table"}.

###### 

Organisms isolated

  *Year*            *1994*   *1995*   *1996*   *1997*   *1998*   *1999*   *2000*   *2001*   *2002*   *2003*   *2004*   *2005*   *2006*   *Total*                                                                                                       
  ----------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ -------------- ------ ------
  Total             379      696      1016     1931     2059     1557     1530     1362     689      972      805      509      634      14131                                                                                                         
  Isolates                                                                                                                                                                                                                                             
  Organisms         No       \%       No       \%       No       \%       No       \%       No       \%       No       \%       No       \%        No.   \%     No.   \%     No.   \%     No.   \%     No.   \%     No.   \%     \*Tested for   No.    \%
  *Klebsiella*      176      46.4     293      42.1     449      44.2     671      34.7     695      33.8     561      36.0     560      36.6      456   33.5   233   33.8   312   32.1   211   26.2   103   20.2   69    10.9   14131          4786   33.9
  *Pseudomonas*     146      38.5     258      37.1     307      30.2     444      23.0     432      21.0     355      22.8     506      33.1      472   34.7   219   31.8   365   37.6   285   35.4   285   56.0   422   66.6   14131          4494   31.8
  *Acinetobacter*   15       4.0      1        0.2      \-       \-       0        \-       0        \-       0        \-       0        \-        0     0.0    0     0.0    0     0.0    0     0.0    0     0.0    0     0.0    14131          16     0.1
  *E. Coli*         \-       \-       19       2.7      67       6.6      349      18.1     265      12.9     147      9.4      113      7.4       141   10.4   121   17.6   217   22.3   227   28.2   81    15.9   79    12.5   14131          1826   12.9
  *Proteus*         \-       \-       3        0.4      20       2.0      2        0.1      50       2.4      42       2.7      51       3.3       20    1.5    5     0.7    11    1.1    18    2.2    5     1.0    1     0.2    14131          228    1.6
  *S. aureus*       33       8.7      115      16.5     173      17.0     465      24.1     539      26.2     415      26.7     280      18.3      248   18.2   101   14.7   59    6.1    55    6.8    35    6.9    58    9.1    14131          2576   18.2
  *S. albus*        9        2.4      4        0.6      \-       \-       0        \-       0        \-       0        \-       0        \-        0     0.0    4     0.6    0     0.0    0     0.0    0     0.0    1     0.2    14131          18     0.1
  Streptococcus     7        \-       3        0.4      \-       \-       0        \-       78       3.8      37       2.4      20       1.3       25    1.8    6     0.9    5     0.5    3     0.4    0     0.0    1     0.2    14131          175    1.2
  Yeast                                                                                                                                                                      3     0.3    6     0.7                 3     0.5    14131          12     0.1

A detailed analysis on individual microorganisms and their antibiotic sensitivities, along with changing trends over this 13-year period is presented. What follows is a bird\'s eye view of the microorganism and its dominant sensitivity pattern.

*Klebsiella* was sensitive to Gatifloxacin (86.3%)

Cefaperazone+Sulbactam (82.8%)

Piperacillin+Tazobactam (77.4%)

Meropenem (72.4%)

Amikacin (66.9%)

Azithromycin (60.4%).

*Pseudomonas* was sensitive to Cefoperazone+Sulbactam (73.9%)

Piperacillin+Tazobactam (72.2%)

Amikacin (62.3%)

Azithromycin (56.3%)

Meropenem (55.8%)

Gatifloxacin (49.9%).

*S. aureus* was sensitive to Sparfloxacin (90.4%)

Cefpirome (80.9%)

Piperacillin+Tazobactum (78.4%)

Netilmicin (77.2%)

Imipenem (64%)

Erythromycin (51.1%).

*E. coli* was sensitive to Ticarcillin+Clavulanic acid (67.2%)

Meropenem (63.6%)

Amikacin (42.7%)

Azithromycin (27.4%)

Gatifloxacin (61.9%)

Cefoperazone+sulbactam (69.1%).

*Proteus* was sensitive to Piperacillin+Tazobactam (97.1%)

Meropenem (82.9%)

Ceftrioxone and Ceftizoxime (64.6%)

Gatifloxacin (62.9%)

Amikacin (55.8%)

Azithromycin (47.8%).

DISCUSSION {#sec1-4}
==========

Thermal injury destroys the barrier function of skin, allowing microbial colonization of wounds and even with the use of topical antimicrobials, contamination of wounds is unavoidable.

The type and amount of microorganisms on and in the injured tissue influence wound healing,\[[@CIT7]\] the frequency of invasive infection and the clinical characteristics of such infections as well as the risk of dissemination. Thus, knowledge of the burn ward microbial flora and the current antibiotic sensitivities at any time is important for the clinician treating burn sepsis.

It has been our observation that when patients are brought to the hospital with exposed burnt areas, the initial swabs reveal no growth. After applying a closed dressing, repeat swabs from the same patient reveal presence of microorganisms. Admittedly, burn biopsy is a better tool to determine microbiological colonization and invasion and for quantitative evaluation. It is also less fallacious. Many centres however, in our country and the world over as well, continue to rely on swab culture reports to initiate treatment as the specimens are easier to obtain and processing time comparatively lesser.

In this study, we found that the most frequent isolates were *Klebsiella* followed by *Pseudomonas* (31.84%). Compared to several earlier reports on burn wound colonization and invasive infection, one of the most striking differences is the frequency of *Klebsiella* in this study, which is contrary to findings in other studies in which Klebsiella formed a small number of total isolates.\[[@CIT1][@CIT8]--[@CIT12]\] It was interesting to note that two units in Nigeria\[[@CIT13][@CIT14]\] also had *Klebsiella* as the most frequent pathogen isolated. The burns unit at Ain Shans University Hospital, Egypt, reported *Klebsiella* as the second most common organism in their study.\[[@CIT19]\]

The pattern of bacterial sensitivities is subject to frequent changes. Its assessment is important for clinical and epidemiological purposes.

For ease of discussion, the various antibiotics were grouped under their respective generic families, e.g.; penicillins, macrolides, quinolones. Antibiotics which did not fit in were placed in the "other antibiotics" group.

Data mining revealed that while *Klebsiella* was the dominant organism from 1994 to 2000, *Pseudomonas* gained the upper hand from 2001. *Klebsiella* was the dominant organism in 2002; subsequently, *Pseudomonas* became the reigning *organism* from 2003 to 2006 (66.6% in 2006 while the percentage of *Klebsiella* is 10.9%). It will be a revelation to us too to see how this pans out. The prevalence of *Escherichia* was on the rise from 2001 to 2004 and it is starting to wean off from 2005 15.9% and 12.5% (2006) in successive years. The percentage incidence of *Staphylococci* is on the decline from 2002 to 2005.

CONCLUSION {#sec1-5}
==========

It may be concluded that the composition of bacterial flora in burns is dependent not only on the depth and extent of the burn but also on the site of burn, the duration of burn, the age of the patient and his/her co-morbidities.\[[@CIT15]\] Burn wound monitoring requires the study of changing bacterial flora and the antibiotic sensitivity reports. Repeated swab cultures and antibiograms are advised for proper selection of antibiotics to control sepsis.\[[@CIT18]\] The development of resistance to a particular antibiotic is dependent on the use of that antibiotic in society at large. Overuse of any antibiotic predisposes to development of resistance. Our unit gets patients from all over Mumbai, other parts of the state of Maharashtra and at times, from other states too. Due to this huge diversity, we have a particular microorganism predominant at a particular point in time, but then, it is also difficult to comment on the source of the changing trends.
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